Newsroom | 4841 results
Sorted by: Latest
-
Luxa to Present Phase 1/2a Clinical and Preclinical Data on RPESC-RPE-4W Therapy for Dry AMD at 2025 ARVO Annual Meeting
FORT LEE, N.J.--(BUSINESS WIRE)--Luxa Biotechnology LLC (Luxa), a clinical-stage biotechnology company developing novel adult retinal pigment epithelial stem cell (RPESC) therapies for dry age-related macular degeneration (dry AMD), today announced the company will present Phase 1/2a clinical and preclinical data on the company’s adult retinal pigment epithelial stem cell (RPESC) therapy for dry age-related macular degeneration (AMD) at the 2025 ARVO Annual Meeting taking place May 4-8, 2025 in...
-
National Vision Appoints Alex Wilkes as CEO
DULUTH, Ga.--(BUSINESS WIRE)--National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) today announced that its Board of Directors has appointed Alex Wilkes as the Company’s next Chief Executive Officer, effective August 1, 2025, and he will join the Company’s Board at that time. Mr. Wilkes succeeds Reade Fahs who will assume the role of Executive Chairman of the Board. Mr. Fahs will continue to work closely with Mr. Wilkes, ensuring a smooth transition. “National Visio...
-
Azalea Vision Raises €9 Million in First Closing of Series A to Further Develop Intelligent Connected Vision Platform
GHENT, Belgium--(BUSINESS WIRE)--Azalea (A-zuh-lay-ah) Vision, a HealthTech company engineering the future of sight, today announced the first closing of its €15 million Series A funding round, raising €9 million along with the appointment of Robert J. Dempsey as Chairman of the Board to guide strategic growth in the European and U.S. markets. "Strong participation from repeat investors in this Series A milestone reaffirms their trust in our medical device and innovation for the future of intel...
-
Heidelberg Engineering Showcases the Future of Imaging Technology at ARVO 2025, Leading the Way From the Lab to the Operating Room
HEIDELBERG, Germany--(BUSINESS WIRE)--Heidelberg Engineering, a global leader in ophthalmic imaging and healthcare data solutions, welcomes delegates at ARVO 2025 to experience the latest research and technological developments behind Heidelberg image quality across a wide range of applications. “We are thrilled to unveil our latest advancements at ARVO," said Dr. Sebastian Rausch, Clinical Development Manager, Investigational Technologies. “These groundbreaking technologies highlight our commi...
-
Astoriom Appoints Ryan Smith as Global Head of Sales
ROCHDALE, England--(BUSINESS WIRE)--Astoriom appoints Ryan Smith as Global Head of Sales to support company in scaling biorepository and stability storage operations....
-
EyeMD EMR Healthcare Systems, Inc., a Leading Healthcare Technology Provider for Ophthalmologists, Announces Significant Growth Investment from Performant Capital
CHICAGO--(BUSINESS WIRE)--EyeMD EMR Healthcare Systems, Inc., (“EyeMD EMR” or “the Company”), a leading provider of healthcare technology software solutions purpose-built for ophthalmologists and eye care specialists, announced a significant majority growth investment from Performant Capital, a Chicago-based private equity firm focused on partnering with and scaling software and technology-enabled businesses. Performant’s investment marks the next step in EyeMD EMR’s growth journey, supporting...
-
CORRECTING and REPLACING EyeCare Partners Presents Latest Innovations in Eye Care at the American Society of Cataract and Refractive Surgery (ASCRS) 2025 in Los Angeles
ST. LOUIS--(BUSINESS WIRE)--EyeCare Partners will bring a strong lineup of clinical research and innovation to the upcoming annual ASCRS meeting....
-
Alcon Elevates Vitreoretinal and Cataract Surgery for Superior Efficiency* with UNITY VCS and UNITY CS
GENEVA--(BUSINESS WIRE)--Alcon Elevates Vitreoretinal and Cataract Surgery for Superior Efficiency* with UNITY VCS and UNITY CS...
-
STAAR Surgical Announces Changes to Board of Directors
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced changes to its Board of Directors. The Company announced that the Board appointed Louis E. Silverman, who served on the Company’s Board from 2014-2022, as a director, effective April 24, 2025. The Company also announced that Aimee S. Weisner, who has served as a director since 2022, has...
-
Ray Therapeutics Awarded $8M CIRM Grant to Advance RTx-015 Gene Therapy for Retinitis Pigmentosa
BERKELEY, Calif.--(BUSINESS WIRE)--Ray Therapeutics Awarded $8M CIRM Grant to Advance RTx-015 Gene Therapy for Retinitis Pigmentosa...